Varlilumab: A Deep Dive into CDX-1127 and its Mechanism Varlilumab (formerly known as PRT-052) represents a promising therapeutic agent targeting the CD27 receptor. This drug's mechanism depends on binding to human https://jemimahpru961418.wikipublicity.com/8743711/text